[Form 4] PRECIGEN, INC. Insider Trading Activity

Rhea-AI Filing Summary

Phil Tennant, Chief Commercial Officer of Precigen, Inc. (PGEN), reported an insider purchase. On 09/29/2025 he acquired 6,000 shares of Precigen common stock at $3.58 per share. Following the transaction he beneficially owned 65,031 shares. The Form 4 was signed on 09/30/2025 by an attorney-in-fact.

Positive

• Insider purchase disclosed: Chief Commercial Officer acquired 6,000 shares at $3.58, showing direct insider buying.
• Complete Section 16 disclosure: Form 4 includes transaction date, price, amount acquired, and post-transaction ownership of 65,031 shares.

Negative

• None.

Insights

Financial Analyst

TL;DR: Insider purchased 6,000 shares at $3.58, increasing holdings to 65,031 shares — a modest but constructive signal.

The reported purchase is a direct acquisition by the company's Chief Commercial Officer and is explicitly recorded at a purchase price of $3.58 per share for 6,000 shares on 09/29/2025. For investors this is a clear, contemporaneous disclosure of insider buying activity which can be interpreted as a vote of confidence by management. The size of the trade is small relative to typical market caps and does not materially change ownership percentages, but it is a factual indicator of insider participation in the equity.

Corporate Governance Expert

TL;DR: Filing properly discloses the officer's purchase and follows Section 16 reporting conventions.

The Form 4 includes required elements: reporting person name and address, relationship to issuer (Chief Commercial Officer), transaction date, transaction code (P), number of shares acquired, price per share, and post-transaction beneficial ownership. The form is signed by an attorney-in-fact on 09/30/2025. There are no amendments, derivatives, or additional explanatory notes included in the filing.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

1. Name and Address of Reporting Person^*

Tennant Phil

(Last) (First) (Middle)

20374 SENECA MEADOWS PARKWAY

(Street)

GERMANTOWN MD 20876

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
PRECIGEN, INC. [ PGEN ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Commercial Officer

3. Date of Earliest Transaction (Month/Day/Year)
09/29/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	09/29/2025		P		6,000	A	$3.58	65,031	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

	/s/ Phil Tennant, by Donald P. Lehr, as attorney-in-fact	09/30/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did Phil Tennant report on Form 4 for PGEN?

He reported acquiring 6,000 shares of Precigen common stock on 09/29/2025 at $3.58 per share, with 65,031 shares owned after the transaction.

What is Phil Tennant's role at Precigen as listed on the filing?

The filing lists Phil Tennant as an Officer, specifically the Chief Commercial Officer.

When was the Form 4 signed and by whom?

The Form 4 shows a signature line dated 09/30/2025, signed by Phil Tennant via an attorney-in-fact, Donald P. Lehr.

Does the filing report any derivative transactions or dispositions?

No. The filing reports a non-derivative acquisition (common stock purchase) and no derivative securities or dispositions are listed.

What transaction code is used on the Form 4?

The transaction is reported with code P, indicating a purchase of the issuer's common stock.